DUBLIN–(BUSINESS WIRE)–The “Nuclear Medicine Global Market Report 2022: Ukraine-Russia War Impact” report has been added to ResearchAndMarkets.com’s offering.
The global nuclear medicine market is expected to grow from $6.00 billion in 2021 to $6.77 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The nuclear medicine market is expected to grow to $11.20 billion in 2026 at a CAGR of 13.4%.
The main types of nuclear medicine are diagnostic and therapeutic. A diagnostic is an examination to identify a person’s distinct areas of strength and weakness to identify a condition, disease, or illness. The applications involved cardiology, lymphoma, thyroid, neurology, oncology, and other applications. The end-users included hospitals and clinics, diagnostic centers, and other end-users.
North America was the largest region in the nuclear medicine market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this nuclear medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The increasing constancy and prevalence of cardiovascular disease (CVD) and cancer are expected to propel the growth of the nuclear medicine market going forward. Cardiovascular diseases (CVDs) are a group of heart and blood vessel disorders, and cancer is a disease in which cells grow out of control and spread to other body parts. Nuclear…
